NEXUS BIOPHARMA INC Research and Development Expense
NEXUS BIOPHARMA INC reported Research and Development Expense of $7.53 thousand for the 3-month period ending 2017-05-31, per its 10-Q filed 2017-10-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-10-27
- NEXUS BIOPHARMA INC research and development expense for the quarter ending 2017-05-31 was $7.53K, a 0.33% increase year-over-year.
- NEXUS BIOPHARMA INC research and development expense for the quarter ending 2017-02-28 was $7.50K, a 50.00% decline year-over-year.
- NEXUS BIOPHARMA INC research and development expense for the quarter ending 2016-11-30 was $7.50K, a 93.05% decline year-over-year.
- NEXUS BIOPHARMA INC research and development expense for the quarter ending 2016-08-31 was $8.90K, a 18.72% increase year-over-year.
- NEXUS BIOPHARMA INC research and development expense for fiscal 2017 was $31.40K, a 86.57% decline from fiscal 2016.
- NEXUS BIOPHARMA INC research and development expense for fiscal 2016 was $233.84K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2017-05-31 | $7.53K 10-Q · filed 2017-10-27 | $15.03K derived: sum of 2 quarters · filed 2017-10-27 | $22.52K derived: sum of 3 quarters · filed 2017-10-27 | $31.43K derived: sum of 4 quarters · filed 2017-10-27 |
| 2017-02-28 | $7.50K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-05 | $15.00K derived: sum of 2 quarters · filed 2017-07-05 | $23.90K derived: sum of 3 quarters · filed 2017-07-05 | $31.40K 10-K · filed 2017-07-05 |
| 2016-11-30 | $7.50K 10-Q · filed 2017-04-10 | $16.40K derived: sum of 2 quarters · filed 2017-04-10 | $23.90K 10-Q · filed 2017-04-10 | $38.90K derived: sum of 4 quarters · filed 2017-10-27 |
| 2016-08-31 | $8.90K 10-Q · filed 2016-10-24 | $16.40K 10-Q · filed 2016-10-24 | $31.40K derived: sum of 3 quarters · filed 2017-10-27 | $139.34K derived: sum of 4 quarters · filed 2017-10-27 |
| 2016-05-31 | $7.50K 10-Q · filed 2017-10-27 | $22.50K derived: sum of 2 quarters · filed 2017-10-27 | $130.44K derived: sum of 3 quarters · filed 2017-10-27 | $137.94K derived: sum of 4 quarters · filed 2017-10-27 |
| 2016-02-29 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-05 | $122.94K derived: sum of 2 quarters · filed 2017-07-05 | $130.44K derived: sum of 3 quarters · filed 2017-07-05 | $233.84K 10-K · filed 2017-07-05 |
| 2015-11-30 | $107.94K 10-Q · filed 2017-04-10 | $115.44K derived: sum of 2 quarters · filed 2017-04-10 | $218.84K 10-Q · filed 2017-04-10 | |
| 2015-08-31 | $7.50K 10-Q · filed 2016-10-24 | $110.90K 10-Q · filed 2016-10-24 |